Reactivity of retinal blood flow to 100% oxygen breathing after lipopolysaccharide administration in healthy subjects

Experimental Eye Research

Volumn 87, Issue 2, 2008, Pages 131-136

  Kolodjaschna, Julia ^a   Berisha, Fatmire ^a   Lasta, Michael ^a   Polska, Elzbieta ^a   Fuchsjäger Mayrl, Gabriele ^a   Schmetterer, Leopold ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

inflammation; laser Doppler velocimetry; oxygen; retinal vascular reactivity; retinal vessel analyzer

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE;

ADULT; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; CELL DENSITY; CONTROLLED STUDY; EYE INFLAMMATION; HEMODYNAMIC PARAMETERS; HUMAN; LASER DOPPLER FLOWMETRY; LEUKOCYTOSIS; MALE; MICROVASCULATURE; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; OXYGEN BREATHING; PRIORITY JOURNAL; RANDOMIZATION; RETINA ARTERY; RETINA BLOOD FLOW; RETINA ISCHEMIA; RETINA MACULA LUTEA; RETINA VEIN; VEIN BLOOD FLOW;

ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CROSS-OVER STUDIES; ERYTHROCYTES; HUMANS; INFLAMMATION; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; LEUKOCYTE COUNT; LEUKOCYTES; LIPOPOLYSACCHARIDES; MICROCIRCULATION; OXYGEN; RETINAL VESSELS; SINGLE-BLIND METHOD;

EID: 48749121760     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.05.006     Document Type: Article

References (46)

1. Albert J., Radomski A., Soop A., Sollevi A., Frostell C., and Radomski M.W. Differential release of matrix metalloprotease-9 and nitric oxide following infusion of endotoxin in human volunteers. Acta Anaesthesiol. Scand. 47 (2003) 407-410
2. Alves-Rodrigues A., and Shao A. The science behind lutein. Toxicol. Lett. 15 (2004) 57-83
3. Bahador M., and Cross A.S. From therapy to experimental model: a hundred years of endotoxin administration to human subjects. J. Endotoxin Res. 13 (2007) 251-279
4. Bilgihan K., Bigihan A., Diker S., Ataoglu O., Dolapci M., Akata F., Hasanreisoglu B., and Turkozkan N. Effects of hyper- and hypo- thyroidism on oxidative stress of the eye in experimental acute anterior uveitis. Acta Ophthalmol. Scand. 74 (1996) 41-43
5. Blum M., Bachmann K., Pietscher S., Brauer-Burchardt C., Vilser W., and Strobel J. Online measurement of retinal artery branches in type II diabetic patients. Initial clinical trials before and after laser coagulation. Ophthalmologe 94 (1997) 724-727
6. Branger J., van den Blink B., Weijer S., Madwed J., Bos C.L., Gupta A., Yong C.L., Polmar S.H., Olszyna D.P., Hack C.E., van Deveter S.J., Peppelenbosch M.P., and van der Poll T. Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J. Immunol. 168 (2002) 4070-4077
7. Bunell E., Lynn M., Habet K., Neumann A., Perdomo C.A., Friedhoff L.T., Rogers S.L., and Parillo J.E. A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia. Crit. Care Med. 28 (2000) 2713-2720
8. Cullinane D.C., Jenkins J.M., Reddy S., VanNatta T., Eddy V.A., Bass J.G., Chen A., Schwartz M., Lavin P., and Morris Jr. J.A. Anterior ischemic optic neuropathy: a complication after systemic inflammatory response syndrome. J. Trauma. 48 (2000) 381-386
9. Florquin S., van den Berg J.G., Olszyna D.P., Claessen N., Opal S.M., Weening J.J., and van der Poll T. Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int. 59 (2001) 2054-2061
10. Fuchsjäger-Mayrl G., Malec M., Polska E., Jilma B., Wolzt M., and Schmetterer L. Effects of granulocyte colony stimulating factor on retinal leukocyte and erythrocyte flux in the human retina. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1520-1524
11. Ilieva I., Ohgami K., Shiratory K., Koyama Y., Yashida K., Kase S., Kitamei H., Takemoto K., Yasawa K., and Ohno S. The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp. Eye Res. 79 (2004) 181-187
12. Jin X.H., Ohgami K., Shiratory K., Suzuki Y., Hirano T., Koyama Y., Yoshida K., Ilieva I., Iseki K., and Ohno S. Inhibitory effects of lutein and endotoxin-induced uveitis in Lewis rats. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2562-2568
13. Kolodjaschna J., Berisha F., Lung S., Schaller G., Polska E., Jilma B., Wolzt M., and Schmetterer L. LPS-induced microvascular leukocytosis can be assessed by the blue field entoptic technique. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H691-H694
14. Kufoy E.A., Fox K., Fox A., Parks C., and Pakalnis V.A. Modulation of the blood-aqueous barrier by gram positive and gram negative bacterial cell wall components in the rat and rabbit. Exp. Eye Res. 50 (1990) 189-195
15. Kulkarni P.S., and Mancino M. Studies on intraocular inflammation produced by intravitreal human interleukins in rabbits. Exp. Eye Res. 56 (1993) 275-279
16. Laengle U.W., Court M., Markstein R., Germann P.G., Nogues V., and Roman D. Effects of anti-glaucoma drugs timolol and GLC756, a novel mixed dopamine D2 receptor agonist and D1 receptor antagonist, on endotoxin-induced-uveitis and -arthritis in rats. Exp. Toxicol. Pathol. 57 (2005) 127-134
17. Lowry S.F. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24 Suppl. 1 (2005) 94-100
18. Lynn M., Wong Y.N., Wheeler J.L., Kao R.J., Perdomo C.A., Noveck R., Vargas R., D'Angelo T., Gotzkowsky S., MacMahon F.G., Wasan K.M., and Rossignol D.P. Extendend in vivo pharmacodynamic activity of E5564 (alpha-D-glucopyranose) in normal volunteers with experimental endotoxemia. J. Pharmacol. Exp. Ther. 308 (2004) 175-181
19. Marsh C.B., and Wewers M.D. The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection. Clin. Chest Med. 17 (1996) 183-197
20. Metrikin D.C., Wilson C.A., Berkowitz B.A., Lam M.K., Wood G.K., and Peshok R.M. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis. Invest. Ophthalmol. Vis. Sci. 36 (1995) 1361-1370
21. Nicolls M.R., Haskins K., and Flores S.C. Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid. Redox Signal 9 (2007) 879-889
22. Ohgami K., Shiratori K., Kotake S., Nishida T., Mizuki N., Yazawa K., and Ohno S. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2694-2701
23. Ohta K., Kikuchi T., Miyahara T., and Yoshimura N. DNA microarray analysis of gene expression in iris and ciliary body of rat eyes with endotoxin-induced uveitis. Exp. Eye Res. 80 (2005) 401-412
24. Ostrowski S.R., Plomgaard P., Fischer C.P., Steensberg A.S., Møller K., Høyer-Hansen G., Pedersen B.K., and Ullum H. Interleukin-6 infusion during human endotoxemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells. Scand. J. Immunol. 61 (2005) 197-206
25. Pleiner J., Heere-Ress E., Langenberger H., Sieder A.E., Bayerle-Eder M., Mittermayer F., Fuchsjäger-Mayrl G., Bohm J., Jansen B., and Wolzt M. Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 95-100
26. Pleiner J., Mittermayer F., Schaller G., MacAllister R.J., and Wolzt M. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation 106 (2002) 1460-1464
27. Pleiner J., Mittermayer F., Schaller G., Marsik C., MacAllister R.J., and Wolzt M. Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J. Am. Coll. Cardiol. 42 (2003) 1656-1662
28. Pleiner J., Schaller G., Mittermayer F., Zorn S., Marsik C., Polterauer S., Kapiotis S., and Wolzt M. Simvastatin prevents vascular hyporeactivity during inflammation. Circulation 110 (2004) 3349-3354
29. Polak K., Dorner G., Kiss B., Polska E., Findl O., Rainer G., Eichler H.G., and Schmetterer L. Evaluation of the Zeiss retinal vessel analyser. Br. J. Ophthalmol. 84 (2000) 1285-1290
30. Riva C.E., and Petrig B. Blue field entoptic phenomenon and blood velocity in the retinal capillaries. J. Opt. Soc. Am. 70 (1980) 1234-1238
31. Riva C.E., Grunwald J.E., Sinclair S.H., and ÓKeefe K. Fundus camera based retinal LD.V. Applied Optics 20 (1981) 117-120
32. Riva C.E., Grunwald J.E., Sinclair S.H., and Petrig B.L. Blood velocity and volumetric flow rate in human retinal vessels. Invest. Ophthalmol. Vis. Sci. 26 (1985) 1124-1132
33. Riva C.E., Grunwald J.E., and Petrig B.L. Autoregulation of human retinal blood flow. An investigation with laser Doppler velocimetry. Invest. Ophthalmol. Vis. Sci. 17 (1986) 1706-1712
34. Rodrigues G.B., Passos G.F., Di Giunta G., Figueiredo C.P., Rodrigues E.B., Grumman Jr. A., Medeiros R., and Calixto J.B. Preventive and therapeutic anti-inflammatory effects of systemic and topical thalidomide on endotoxin-induced uveitis in rats. Exp. Eye Res. 84 (2007) 553-560
35. Romanovsky A.A., Shido O., Sakurada S., Sugimoto N., and Nagasaka T. Endotoxin shock: thermoregulatory mechanisms. Am. J. Physiol. 270 (1996) R693-R703
36. Schmetterer L., and Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 42 (1999) 387-405
37. Soop M., Duxbury H., Agwunobi A.O., Gibson J.M., Hopkins S.J., Childs C., Cooper R.G., Maycock P., Little R.A., and Carlson G.L. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E1276-E1285
38. Soop A., Albert J., Weitzberg E., Bengtsson A., Lundberg J.O., and Sollevi A. Complement activation, endothelin-1 and neuropeptide Y in relation to the cardiovascular response to endotoxin-induced systemic inflammation in healthy volunteers. Acta Anaesthesiol. Scand. 48 (2004) 74-81
39. Suffredini A.F., Fromm R.E., Parker M.M., Brenner M., Kovacs J.A., Wesley R.A., and Parillo J.A. The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321 (1989) 280-287
40. Suffredini A.F., Hochstein H.D., and McMahon F.G. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O: 113 endotoxin. J. Infect. Dis. 179 (1999) 1278-1282
41. Suzuki Y., Ohgami K., Shiratori K., Yin X.H., Ilieva I., Koyama Y., Yazawa K., Yoshida K., Kase S., and Ohno S. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway. Exp. Eye Res. 82 (2006) 275-281
42. Tilton R.G., Chang K., Corbett J.A., Misko T.P., Currie M.G., Bora N.S., Kaplan H.G., and Williamson J.R. Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest. Ophthalmol. Vis. Sci. 35 (1994) 3278-3288
43. Wangsa-Wirawan N.D., and Linsenmeier R.A. Retinal oxygen: fundamental and clinical aspects. Arch. Ophthalmol. 121 (2003) 547-557
44. Wilson M., Blum R., Dandona P., and Mousa S. Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecules and inflammatory markers: a model of human diseases. Clin. Exp. Pharmacol. Physiol. 28 (2001) 376-380
45. Yadav U.C., Srivastava S.K., and Ramana K.V. Aldose reductase inhibition prevents endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 48 (2007) 4634-4642
46. Yomura Y., Shoji Y., Asai D., Murakami E., Ueno S., and Nakashima H. Direct, real-time, simultaneous monitoring of intravitreal nitric oxide and oxygen in endotoxin-induced uveitis in rabbits. Life Sci. 80 (2007) 1449-1457